Introduction {#sec1}
============

Computed tomography enterography (CTE) is an imaging technique, developed for assessing small bowel diseases. CTE is based on obtaining intravenous contrast-material enhanced abdominopelvic computed tomography (CT) images after oral contrast agent (OCA) administration for optimal small bowel distension and bowel tissue discrimination \[[@cit0001]\]. The advantages of this technique are being non-invasive, enabling high-resolution images, and the evaluation of both enteric and extra-enteric structures \[[@cit0002]\]. CTE is a more cost-effective imaging method, which provides faster imaging with higher spatial and temporal resolution than magnetic resonance elastography (MRE). Another superiority of CTE to MRE is the ability of luminal navigation. Indications are diagnosis and follow-up of inflammatory bowel diseases, diarrhoea, gastrointestinal tract bleeding, small bowel obstruction, neoplasm, polyposis syndromes, or radiation enteritis \[[@cit0003],[@cit0004]\]. Inadequate bowel distension can result in misdiagnoses, such as; wall thickening, abnormal mural enhancement, or obscuring of intra-luminal lesions \[[@cit0003],[@cit0005],[@cit0006]\]. Polyethylenoglycol (PEG), water, methylcellulose, mannitol, and low-concentration barium with sorbitol have been studied as OCAs for CTE in literature \[[@cit0001]-[@cit0004]\]. However, water cannot provide optimal luminal distension because of rapid absorption, and other OCAs can cause adverse effects like diarrhoea, spasm, nausea, and vomiting. Which OCAs should be used for CTE to obtain adequate luminal distension with the least adverse effect is still controversial. Therefore, we developed a new mixture of OCA, showing characteristics of both negative and positive agents, which was composed of water, methylcellulose, lactulose, locust bean gum, and sorbitol. The aim of this study was to show the characteristics of the new mixture and to compare the luminal distension and radiological confidence of the solution with the water-lactulose mixture.

Material and methods {#sec2}
====================

CTE images from a three-year period (performed between 2013 and 2016) were included in our institutional review board-approved, retrospective study after informed consent was obtained. Inclusion criteria were the evaluation of diarrhoea, gastrointestinal (GI) tract bleeding, inflammatory bowel disease, coeliac disease, or small bowel tumour. Exclusion criteria were an allergy to contrast materials, renal insufficiency, pregnancy, claustrophobia, galactose intolerance, GI tract obstruction, and paediatric age. Ninety-one patients drank lactulose-water mixture (Group 1), and 54 patients drank the new mixture (Group 2). Patients were assigned to the groups in random order.

Imaging protocol and preparation of the oral contrast agents {#sec2.1}
------------------------------------------------------------

A bowel cleansing diet and 50 ml laxative diet solution (X-M diet solution, Yenisehir Laboratory, Ankara, Turkey) were administered to the patients the night before and on the morning of the examination. All patients were asked to drink a total of 1500 ml of OCA in 50 minutes -- 300 ml every 10 minutes. In patients with suspicious low/moderate-grade small bowel obstruction, extra-intestinal fluid collection, fistulae, or radiation enteritis the OCA was mixed with 40 ml Iopromide (Ultravist, Schering, Germany) in addition to the other substances, for both of the groups.

The patients in Group 1 drank 1500 ml of OCA, composed of 200 ml (670 mg/ml) lactulose and 1300 ml water. The patients in Group 2 drank a total of 1500 ml mixture of water with 10 g hydroxypropyl-methylcellulose, 10 g lactulose, 5 g locust bean gum, and 5 g sorbitol. Although the ingredients of the mixture are well known OCAs, as far as we know they have not been used in this combination before.

Patients who drank the OCA were taken to a 64-detector row multiple detector computed tomography (MDCT) machine (Aquilion 64, Toshiba, Tokyo, Japan). Images were obtained from the level of the diaphragm to the level of the symphysis pubis, in the enteric phase (60 seconds) after the intravenous administration of 100 ml of Iopromide (Ultravist, Schering, Germany) at a flow rate of 3 ml/s. Multiphasic CTE was performed for occult GI tract bleeding. In order to decrease the intestinal motility, a spasmolytic agent, 20 mg of hyoscine-*N*-butylbromide (Buscopan, Boehringer Ingelheim Ltd, Bracknell, UK), was given intravenously immediately before the scanning. Images were obtained with 2 mm slice thickness and reconstructed in 1 mm slice thickness. Coronal and sagittal reformatted images were also formed.

Image analysis {#sec2.2}
--------------

CTE images were evaluated by two radiologists (O.A., S.E.) independently. The second observer also evaluated the same data three weeks later for the intra-observer statistics. They were blinded to the pre-diagnosis, clinical, and laboratory findings of the patients. The authors were also blinded as to which contrast agent was used. They had not seen the images before the study.

The GI tract was divided into 11 segments for scoring, as follows: stomach, duodenum, jejunum, ileum, ileocecal area, cecum, ascending colon, transverse colon, descending colon, sigmoid colon, and rectum. Each segment was graded for distension and radiological confidence. Grading of luminal distension was as follows: score 0, collapsed segment; score 1, poor distension; score 2, moderate distension; score 3, good distension. Radiological confidence is the opinion of the observer about whether the lumen and wall of the GI segment can be evaluated with confidence in regard to the luminal distension and technical aspects. Grading of radiological confidence was scored as 0: poor, 1: good, 2: excellent.

Statistical analysis {#sec2.3}
--------------------

Age values were reported as median (minimum: maximum) values and compared between groups using the Mann- Whitney *U* test. Raters' scores were compared between groups by using the Pearson χ^2^ test and Freeman-Halton test. A weighted kappa (κ) statistic with 95% confidence intervals was calculated for assessment of inter-reader and intra-reader reliability. Kappa coefficient less than 0.20 was interpreted as poor agreement, 0.21 to 0.40 as fair agreement, 0.41 to 0.60 as moderate agreement, 0.61 to 0.80 as good agreement, and 0.81 to 1.00 as very good agreement \[[@cit0007]\]. SPSS software version 20.0 was used for performing statistical analysis. Statistically, significance was set at *p* \< 0.05.

Results {#sec3}
=======

The demographic characteristics of the patients were as follows; the median age of Group 1 and 2 was 53.50 (18-84) and 50.50 (22-84), respectively. Fifty-five patients were male (61.1%) and 35 were female (38.9%) in Group 1. Thirty-six of patients were male (64.8%) and 19 were female (35.2%) in Group 2. There was no significant difference between the groups in terms of age (*p* = 0.184) and gender (*p* = 0.657).

Inflammatory bowel disease was detected in 13 patients, four of them had an enteric fistula, and one of them had a perianal fistula. GI tract tumour was detected in 12 patients. One of them was histopathologically diagnosed with FAP-associated desmoid tumour. A postoperative fistula between neobladder-ileum was depicted in a patient, whose CTE was performed for postoperative imaging.

Five patients could not drink all of the mixture because of nausea or the taste of the mixture, and two patients had diarrhoea in Group 1. Three patients could not drink all of the mixture because of nausea or the taste of the mixture, one patient vomited, and two patients had diarrhoea in Group 2. In general, the tolerability of the mixture was high. These adverse effects regressed within 24 h.

In general, inter-reader reliabilities of distension and for radiological confidence scores were moderate or good for both groups and gastrointestinal segments (*p* \< 0.001, [Table 1](#t0001){ref-type="table"}; [Figures 1](#f0001){ref-type="fig"} and [2](#f0002){ref-type="fig"}). Lower agreement values were detected for duodenum and jejunum scores. At the same time, the best κ values were obtained in sigmoid colon assessments ([Table 1](#t0001){ref-type="table"}).

###### 

Inter-reader reliabilities of distension and radiological confidence scores for the groups

                           Distension   Radiological confidence                                 
  ------------------------ ------------ ------------------------- ---------- ------ ----------- ----------
  **Group 1 (*n* = 91)**                                                                        
  Stomach                  0.62         0.48-0.76                 \< 0.001   0.84   0.67-1.00   \< 0.001
  Duodenum                 0.59         0.46-0.73                 \< 0.001   0.68   0.53-0.83   \< 0.001
  Jejunum                  0.52         0.39-0.65                 \< 0.001   0.61   0.47-0.75   \< 0.001
  Ileum                    0.47         0.35-0.60                 \< 0.001   0.61   0.46-0.75   \< 0.001
  Ileocecal area           0.61         0.47-0.74                 \< 0.001   0.53   0.39-0.67   \< 0.001
  Cecum                    0.73         0.58-0.87                 \< 0.001   0.75   0.59-0.91   \< 0.001
  Ascending colon          0.73         0.59-0.86                 \< 0.001   0.90   0.75-1.00   \< 0.001
  Transverse colon         0.69         0.56-0.82                 \< 0.001   0.90   0.75-1.00   \< 0.001
  Descending colon         0.75         0.60-0.89                 \< 0.001   0.85   0.69-1.00   \< 0.001
  Sigmoid                  0.91         0.76-1.00                 \< 0.001   0.90   0.72-1.00   \< 0.001
  Rectum                   0.88         0.73-1.00                 \< 0.001   0.91   0.75-1.00   \< 0.001
  **Group 2 (*n* = 54)**                                                                        
  Stomach                  0.91         0.69-1.00                 \< 0.001   0.60   0.43-0.77   \< 0.001
  Duodenum                 0.44         0.27-0.62                 \< 0.001   0.45   0.30-0.60   \< 0.001
  Jejunum                  0.46         0.28-0.64                 \< 0.001   0.63   0.43-0.82   \< 0.001
  Ileum                    0.64         0.45-0.84                 \< 0.001   0.69   0.45-0.83   \< 0.001
  Ileocecal area           0.22         0.03-0.42                 0.013      0.66   0.46-0.87   \< 0.001
  Cecum                    0.37         0.17-0.56                 \< 0.001   0.49   0.30-0.69   \< 0.001
  Ascending colon          0.46         0.29-0.63                 \< 0.001   0.70   0.48-0.92   \< 0.001
  Transverse colon         0.59         0.42-0.76                 \< 0.001   0.77   0.55-0.99   \< 0.001
  Descending colon         0.71         0.53-0.90                 \< 0.001   0.89   0.66-1.00   \< 0.001
  Sigmoid                  0.79         0.60-0.97                 \< 0.001   0.95   0.72-1.00   \< 0.001
  Rectum                   0.72         0.52-0.92                 \< 0.001   0.86   0.63-1.00   \< 0.001

![Computed tomography enterography (CTE), obtained with lactulose and water the new mixture, in a 66-year-old woman with elevated CEA levels and abdominal pain. In this patient, magnetic resonance elastography examination was not performed due to lumbar level metallic screws, and therefore CTE was performed. There is no abnormality in bowels or mesentery. Distension and radiological confidence scores were good to moderate for all segments](PJR-84-38575-g001){#f0001}

![Computed tomography enterography, obtained with the new mixture, in a 65-year-old man with abdominal discomfort. These images reveal no abnormalities within the GIS or in the adjacent mesentery. Bowel wall thicknesses are normal, and there are good to excellent distention scores for all segments](PJR-84-38575-g002){#f0002}

According to distension scores of reader 1, Group 2 showed better results in all of the segments than Group 1, except for the duodenum, where no significant difference was observed between the groups ([Table 2](#t0002){ref-type="table"}). The confidence scoring of the reader also showed similar results. The new mixture was more successful in all of the segments except for the duodenum and jejunum, where no significant difference was observed between the groups ([Table 3](#t0003){ref-type="table"}, [Figure 3](#f0003){ref-type="fig"}).

###### 

Distension scores of rater 1

  Distension -- rater 1   Collapsed            Moderate    Good        Excellent   *p*-value   
  ----------------------- -------------------- ----------- ----------- ----------- ----------- ----------
  Stomach                 Group 1 (*n* = 90)   5 (5.6)     11 (12.2)   28 (31.1)   46 (51.1)   0.007
  Group 2 (*n* = 52)      1 (1.9)              1 (1.9)     9 (17.3)    41 (78.8)               
  Duodenum                Group 1 (*n* = 83)   20 (24.1)   31 (37.3)   27 (32.5)   5 (6)       0.124
  Group 2 (*n* = 53)      8 (15.1)             28 (52.8)   11 (20.8)   6 (11.3)                
  Jejunum                 Group 1 (*n* = 91)   16 (17.6)   39 (42.9)   27 (29.7)   9 (9.9)     0.043
  Group 2 (*n* = 53)      2 (3.8)              27 (50.9)   14 (26.4)   10 (18.9)               
  Ileum                   Group 1 (*n* = 91)   9 (9.9)     49 (53.8)   24 (26.4)   9 (9.9)     \< 0.001
  Group 2 (*n* = 53)      0 (0)                14 (26.4)   22 (41.5)   17 (32.1)               
  Ileocecal area          Group 1 (*n* = 89)   15 (16.9)   37 (41.6)   22 (24.7)   15 (16.9)   \< 0.001
  Group 2 (*n* = 46)      0 (0)                5 (10.2)    13 (26.5)   31 (63.3)               
  Cecum                   Group 1 (*n* = 90)   6 (6.7)     55 (61.1)   12 (13.3)   17 (18.9)   \< 0.001
  Group 2 (*n* = 48)      0 (0)                2 (4.2)     8 (16.7)    38 (79.2)               
  Ascending colon         Group 1 (*n* = 91)   11 (12.1)   57 (62.6)   8 (8.8)     15 (16.5)   \< 0.001
  Group 2 (*n* = 48)      2 (4.2)              3 (6.3)     11 (22.9)   32 (66.7)               
  Transverse colon        Group 1 (*n* = 91)   24 (26.4)   44 (48.4)   14 (15.4)   9 (9.9)     \< 0.001
  Group 2 (*n* = 48)      4 (8.3)              5 (10.4)    19 (39.6)   20 (41.7)               
  Descending colon        Group 1 (*n* = 91)   44 (48.4)   26 (26.6)   14 (15.4)   7 (7.7)     \< 0.001
  Group 2 (*n* = 48)      6 (12.5)             9 (18.8)    20 (41.7)   13 (27.1)               
  Sigmoid                 Group 1 (*n* = 85)   33 (38.8)   31 (36.5)   17 (20)     4 (4.7)     \< 0.001
  Group 2 (*n* = 49)      6 (12.2)             14 (28.6)   14 (28.6)   15 (30.6)               
  Rectum                  Group 1 (*n* = 84)   23 (27.4)   40 (47.6)   14 (16.7)   7 (8.3)     \< 0.001
  Group 2 (*n* = 48)      4 (8.3)              10 (20.8)   11 (22.9)   23 (47.9)               

Values expressed as *n* (%)

###### 

Radiological confidence scores of rater 1

  Confidence -- rater 1   Poor                 Good        Excellent   *p*-value   
  ----------------------- -------------------- ----------- ----------- ----------- ----------
  Stomach                 Group 1 (*n* = 90)   7 (7.8)     18 (20)     65 (72.2)   0.014
  Group 2 (*n* = 52)      2 (3.8)              2 (3.8)     48 (92.3)               
  Duodenum                Group 1 (*n* = 83)   28 (33.7)   38 (45.8)   17 (20.5)   0.743
  Group 2 (*n* = 53)      21 (39.6)            21 (39.6)   11 (20.8)               
  Jejunum                 Group 1 (*n* = 91)   22 (24.2)   44 (48.4)   25 (27.5)   0.532
  Group 2 (*n* = 53)      10 (18.9)            24 (45.3)   19 (35.8)               
  Ileum                   Group 1 (*n* = 91)   18 (19.8)   48 (52.7)   25 (27.5)   \< 0.001
  Group 2 (*n* = 53)      1 (1.9)              16 (30.2)   36 (67.9)               
  Ileocecal area          Group 1 (*n* = 89)   22 (24.7)   36 (40.4)   31 (34.8)   \< 0.001
  Group 2 (*n* = 49)      0 (0)                5 (10.2)    44 (89.8)               
  Cecum                   Group 1 (*n* = 90)   6 (6.7)     58 (64.4)   26 (28.9)   \< 0.001
  Group 2 (*n* = 48)      0 (0)                3 (6.3)     45 (93.8)               
  Ascending colon         Group 1 (*n* = 91)   14 (15.4)   59 (64.8)   18 (19.8)   \< 0.001
  Group 2 (*n* = 48)      3 (6.3)              6 (12.5)    39 (81.3)               
  Transverse colon        Group 1 (*n* = 91)   26 (28.6)   49 (53.8)   16 (17.6)   \< 0.001
  Group 2 (*n* = 48)      4 (8.3)              7 (14.6)    37 (77.1)               
  Descending colon        Group 1 (*n* = 91)   44 (48.4)   32 (35.2)   15 (16.5)   \< 0.001
  Group 2 (*n* = 48)      6 (12.5)             12 (25)     30 (62.5)               
  Sigmoid                 Group 1 (*n* = 85)   35 (41.2)   37 (43.5)   13 (15.3)   \< 0.001
  Group 2 (*n* = 49)      6 (12.2)             14 (28.6)   29 (59.2)               
  Rectum                  Group 1 (*n* = 84)   25 (29.8)   46 (54.8)   13 (15.5)   \< 0.001
  Group 2 (*n* = 48)      4 (8.3)              10 (20.8)   34 (70.8)               

Values expressed as *n* (%)

![Computed tomography enterography images of four different patients. Upper-line images belong to Group 1 (lactulose and water mixture). Lower line images belong to Group 2 (the new mixture). The new mixture seems to be more effective in providing adequate ileal and colonic distention](PJR-84-38575-g003){#f0003}

Group 2 showed better results than Group 1 for ileum and colonic segments, according to the distension and confidence scorings of reader 2. Although no significant difference was found for the duodenum and jejunum, good distension and confidence agreements were observed for these segments ([Table 4](#t0004){ref-type="table"}).

###### 

Distension and radiological confidence scores of rater 2

  Distension -- rater 2       Collapsed            Moderate    Good            Excellent       *p*-value   
  --------------------------- -------------------- ----------- --------------- --------------- ----------- ----------
  Stomach                     Group 1 (*n* = 89)   5 (5.6)     11 (12.4)       26 (29.2)       47 (52.8)   0.003
  Group 2 (*n* = 52)          1 (1.9)              1 (1.9)     7 (13.5)        43 (87.2)                   
  Duodenum                    Group 1 (*n* = 83)   5 (6)       35 (42.2)       38 (45.8)       5 (6)       0.513
  Group 2 (*n* = 53)          1 (1.9)              26 (49.1)   21 (39.6)       5 (9.4)                     
  Jejunum                     Group 1 (*n* = 91)   5 (5.5)     34 (37.4)       36 (39.6)       16 (17.6)   0.403
  Group 2 (*n* = 53)          1 (1.9)              15 (28.3)   28 (52.8)       9 (17)                      
  Ileum                       Group 1 (*n* = 91)   1 (1.1)     29 (31.9)       52 (57.1)       9 (9.9)     0.007
  Group 2 (*n* = 53)          0 (0)                7 (13.2)    32 (60.4)       14 (26.4)                   
  Ileocecal area              Group 1 (*n* = 89)   7 (7.9)     34 (38.2)       41 (46.1)       7 (7.9)     \< 0.001
  Group 2 (*n* = 46)          0 (0)                1 (2)       30 (61.2)       18 (36.7)                   
  Cecum                       Group 1 (*n* = 90)   6 (6.7)     41 (45.6)       30 (33.3)       13 (14.4)   \< 0.001
  Group 2 (*n* = 48)          0 (0)                3 (6.3)     23 (47.9)       22 (45.8)                   
  Ascending colon             Group 1 (*n* = 91)   10 (11)     45 (49.5)       27 (29.7)       9 (9.9)     \< 0.001
  Group 2 (*n* = 48)          2 (4.2)              3 (6.3)     28 (58.3)       15 (31.3)                   
  Transverse colon            Group 1 (*n* = 91)   18 (19.8)   42 (46.2)       25 (27.5)       6 (6.6)     \< 0.001
  Group 2 (*n* = 48)          4 (8.3)              5 (10.4)    30 (62.5)       9 (18.8)                    
  Descending colon            Group 1 (*n* = 91)   34 (37.4)   34 (37.4)       20 (22)         3 (3.3)     \< 0.001
  Group 2 (*n* = 48)          4 (8.3)              10 (20.8)   27 (56.3)       7 (14.6)                    
  Sigmoid                     Group 1 (*n* = 85)   30 (35.3)   33 (38.8)       19 (22.4)       3 (3.5)     \< 0.001
  Group 2 (*n* = 49)          5 (10.2)             14 (28.6)   22 (44.9)       8 (16.3)                    
  Rectum                      Group 1 (*n* = 84)   21 (25)     42 (50)         17 (20.2)       4 (4.8)     \< 0.001
  Group 2 (*n* = 48)          3 (6.3)              11 (22.9)   20 (41.7)       14 (29.2)                   
  **Confidence -- rater 2**   **Poor**             **Good**    **Excellent**   ***p*-value**               
  Stomach                     Group 1 (*n* = 89)   6 (6.7)     26 (29.2)       57 (64)         0.057       
  Group 2 (*n* = 52)          1 (1.9)              8 (15.4)    43 (82.7)                                   
  Duodenum                    Group 1 (*n* = 83)   17 (20.5)   51 (61.4)       15 (18.1)       0.059       
  Group 2 (*n* = 53)          3 (5.7)              39 (73.6)   11 (20.8)                                   
  Jejunum                     Group 1 (*n* = 91)   8 (8.8)     60 (65.9)       23 (25.3)       0.409       
  Group 2 (*n* = 53)          2 (3.8)              34 (64.2)   17 (32.1)                                   
  Ileum                       Group 1 (*n* = 91)   7 (7.7)     64 (70.3)       20 (22)         \< 0.001    
  Group 2 (*n* = 53)          0 (0)                25 (47.2)   28 (52.8)                                   
  Ileocecal area              Group 1 (*n* = 89)   10 (11.2)   62 (69.7)       17 (19.1)       \< 0.001    
  Group 2 (*n* = 49)          0 (0)                11 (22.4)   38 (77.6)                                   
  Cecum                       Group 1 (*n* = 90)   9 (10)      60 (66.7)       21 (23.3)       \< 0.001    
  Group 2 (*n* = 48)          0 (0)                9 (18.8)    39 (81.3)                                   
  Ascending colon             Group 1 (*n* = 91)   13 (14.3)   62 (68.1)       16 (17.6)       \< 0.001    
  Group 2 (*n* = 48)          2 (4.2)              14 (29.2)   32 (66.7)                                   
  Transverse colon            Group 1 (*n* = 91)   23 (25.3)   55 (60.4)       13 (14.3)       \< 0.001    
  Group 2 (*n* = 48)          4 (8.3)              15 (31.3)   29 (60.4)                                   
  Descending colon            Group 1 (*n* = 91)   41 (45.1)   40 (44)         10 (11)         \< 0.001    
  Group 2 (*n* = 48)          5 (10.4)             16 (33.3)   27 (56.3)                                   
  Sigmoid                     Group 1 (*n* = 85)   35 (41.2)   41 (48.2)       9 (10.6)        \< 0.001    
  Group 2 (*n* = 49)          6 (12.2)             16 (32.7)   27 (55.1)                                   
  Rectum                      Group 1 (*n* = 84)   23 (27.4)   51 (60.7)       10 (11.9)       \< 0.001    
  Group 2 (*n* = 48)          3 (6.3)              13 (27.1)   32 (66.7)                                   

Values were expressed as *n* (%)

According to the intra-reader agreement analyses of reader 2, there were excellent agreement values for each segment for all cases ([Table 5](#t0005){ref-type="table"}). Lower agreement values were detected for duodenum and jejunum segments. At the same time, the best κ values were obtained in sigmoid colon and rectum assessments ([Table 5](#t0005){ref-type="table"}).

###### 

Intra-reader reliabilities of distension and radiological confidence scores of reader 2

  Rater 2            Distension   Confidence                                 
  ------------------ ------------ ------------ ---------- ------ ----------- ----------
  Stomach            0.92         0.92-1.00    \< 0.001   0.97   0.83-1.00   \< 0.001
  Duodenum           0.87         0.75-0.99    \< 0.001   0.86   0.74-0.98   \< 0.001
  Jejunum            0.87         0.75-0.98    \< 0.001   0.85   0.72-0.98   \< 0.001
  Ileum              0.88         0.76-0.99    \< 0.001   0.87   0.74-1.00   \< 0.001
  Ileocecal area     0.89         0.77-1.00    \< 0.001   0.87   0.74-1.00   \< 0.001
  Cecum              0.91         0.79-1.00    \< 0.001   0.94   0.80-1.00   \< 0.001
  Ascending colon    0.88         0.77-1.00    \< 0.001   0.97   0.84-1.00   \< 0.001
  Transverse colon   0.87         0.76-0.98    \< 0.001   0.94   0.82-1.00   \< 0.001
  Descending colon   0.87         0.76-0.98    \< 0.001   0.96   0.84-1.00   \< 0.001
  Sigmoid            0.94         0.82-1.00    \< 0.001   0.98   0.85-1.00   \< 0.001
  Rectum             0.95         0.83-1.00    \< 0.001   0.98   0.85-1.00   \< 0.001

Discussion {#sec4}
==========

Our results showed that the new mixture was significantly more successful than the lactulose-water mixture according to distension and radiological confidence scores. We also observed adequate distension in colonic segments to provide optimal evaluation of colonic involvement in inflammatory diseases without the need for extra contrast agent administration. We demonstrated that the new mixture can also be used in MRE and provide adequate luminal distension \[[@cit0008]\]. Therefore, MRI can be preferred for imaging the colonic segments with late images.

There were variations in the distension scores of the intestinal segments, which might be a consequence of the variations in the intestinal motility amongst the patients. Drinking 250-500 ml of water in addition to the mixture just before the imaging can be useful for stomach distension or obtaining late-phase additional images can increase the colonic distension. The imaging protocol can be arranged according to the pre-diagnosis or the history of the patient.

For the most part, intra- and inter-reader reliabilities were good for the groups. Lower agreement values were detected for duodenum and jejunum scores, and the best κ values were obtained in sigmoid colon assessments. This situation proves that the CTE technique with the new mixture is effective and reliable. The reason for the low agreement values in duodenum and jejunum may be the faster OCA discharge of these segments. If any abnormality is investigated in these regions, we think that additional fluid intake will increase the efficacy and/or reliability before the CTE.

CTE has become one of the most important imaging modalities for small bowel imaging. Endoscopy-colonoscopy, capsule endoscopy, small bowel follow-through, conventional/CT/MR enteroclysis, MRE are the other imaging techniques for evaluating small bowel diseases.

Endoscopic techniques can provide mucosal visualisation, but extra-intestinal structures cannot be evaluated. Jejunum and ileum cannot be visualised by endoscopy or colonoscopy. Also, capsule endoscopy is contraindicated for bowel obstruction and stricture suspected cases \[[@cit0009]-[@cit0011]\]. Enteroclysis-based techniques are centred on OCA administration via nasojejunal intubation \[[@cit0005]\]. Therefore, it is an invasive method, which provides adequate bowel distension. Also, additional ionising radiation exposure due to duodenal catheter placement is an additional disadvantage of the enteroclysis \[[@cit0011],[@cit0012]\].

CTE is a non-invasive, well-tolerated method that can evaluate luminal, mural, and extra-intestinal abnormalities. It provides high resolution, multiplanar reformatted images \[[@cit0013]-[@cit0015]\]. CTE is the fastest and the most appropriate imaging modality for evaluating active inflammatory bowel disease and its complications \[[@cit0016]\]. The only disadvantage of this technique is the radiation exposure \[[@cit0017]\]. MRE overcomes this disadvantage, so it is preferred for follow-up imaging of inflammatory bowel disease in paediatric patients \[[@cit0018],[@cit0019]\]. On the other hand, MRE is more time consuming and expensive. The image quality is also variable in MR imaging. CTE can provide better image quality in patients who cannot hold their breath during imaging. The radiation exposure dose is the same as abdominal-pelvic venous phase CT, and it can be reduced by using a dose modulation option and advanced reconstruction techniques \[[@cit0020]\].

Inadequate luminal distension can cause misinterpretation such as wall thickening, abnormal mural enhancement, or obscuring of intraluminal lesions \[[@cit0005],[@cit0006]\]. Therefore, obtaining optimal luminal distension is crucial for a good-quality CTE. OCAs used for this purpose are classified into two groups such as negative/neutral and positive. Water, lactulose, oil emulsion, Mucofalk, methylcellulose, polyethylene glycol (PEG), mannitol, locust bean gum, swollen fibre laxatives, and sorbitol are negative OCAs. Water with iodine-based contrast (ultra-low dose) agent mixtures are positive OCAs \[[@cit0006],[@cit0010],[@cit0021],[@cit0022]\].

Negative OCAs increases the visibility of mural enhancement by increasing the contrast difference between the lumen and the intestinal wall \[[@cit0006],[@cit0009],[@cit0023]-[@cit0028]\]. Positive OCAs help in the differentiation of intraluminal versus extraluminal pathologies and make the extra-intestinal fluid collections more apparent. They can obscure mural and mucosal enhancement in inflammatory bowel diseases or obscure GI tract bleeding \[[@cit0029],[@cit0030]\]. Also, if the images are obtained in the arterial phase (CT angiography), these contrast agents will create difficulty in the evaluation of vascular structures \[[@cit0006],[@cit0028],[@cit0031]-[@cit0038]\]. Positive OCAs are useful for detecting the localisation of fistulas and obstruction \[[@cit0029]\].

Our new mixture is a negative OCA. If the iodine-based contrast media is mixed into the OCA, the final mixture also shows characteristics of positive OCAs, which aids in assessing extra-luminal pathologies such as fluid collections (e.g. abscess, cystic lesions, etc.), without obscuring mural or mucosal enhancement. Lactulose, sorbitol, and methylcellulose inhibit water absorption. Methylcellulose is the one with the fewest adverse effects amongst the OCAs, and hence it increases the luminal distension without increasing the adverse effects.

The optimal volume of OCA, considering adequate luminal distension, patient tolerance, and adverse effects have been discussed in the literature \[[@cit0039]\]. Maglinte *et al*. observed that 1.5 l was not enough for small bowel distension in active inflammatory bowel disease assessment, but they also mentioned that they could have obtained good-quality images with fewer volumes \[[@cit0040]\]. Kuehle *et al*. used a 1 l solution of 2.5% mannitol and 0.2% locust bean gum in their study and observed an increase in adverse effects but not in distension when they increased the volume to 1200-1500 ml \[[@cit0041]\]. Boudiaf *et al*. performed CT enteroclysis with 2 l water and observed poor distension in only two of the 107 patients in their study \[[@cit0024]\]. The amount of OCA used in studies ranges between 1300 and 2000 ml \[[@cit0028],[@cit0042]-[@cit0044]\], so we used 1500 ml of OCA mixture in our study.

The limitations of the study were as follows: not all of the patients succeeded in drinking all of the solutions -- some of them vomited before the imaging, but this a handicap of all of the OCAs discussed in the studies. We could only compare our mixture with water-lactulose solution because most of the other OCAs are not readily available in our country.

Conclusions {#sec5}
===========

The new mixture can provide good-quality images with optimal luminal distension. Inter- and intra-reader reliabilities of the new mixture were good or excellent (especially for ileum and colonic assessments). The new mixture is more efficient and reliable for ileum and colon. We think that using the new mixture can increase the radiological confidence in CTE evaluations.
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